Patent details

EP2804602 Title: USE OF SUBSTITUTED HEXITOLS INCLUDING DIANHYDROGALACTITOL AND ANALOGS TO TREAT NEOPLASTIC DISEASE AND CANCER STEM CELLS INCLUDING GLIOBLASTOMA MULTFORME AND MEDULLOBLASTOMA

Basic Information

Publication number:
EP2804602
PCT Application Number:
US2013022505
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP137382073
PCT Publication Number:
WO2013110058
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF SUBSTITUTED HEXITOLS INCLUDING DIANHYDROGALACTITOL AND ANALOGS TO TREAT NEOPLASTIC DISEASE AND CANCER STEM CELLS INCLUDING GLIOBLASTOMA MULTFORME AND MEDULLOBLASTOMA
French Title of Invention:
UTILISATION D'HEXITOLS SUBSTITUÉS, Y COMPRIS LE DIANHYDROGALACTITOL ET SES ANALOGUES, POUR LE TRAITEMENT DE CELLULES SOUCHES DE MALADIES NÉOPLASIQUES ET DE CANCERS, Y COMPRIS LE GLIOBLASTOME MULTIFORME ET LE MÉDULLOBLASTOME
German Title of Invention:
VERWENDUNG VON SUBSTITUIERTEN HEXITOLEN MIT DIANHYDROGALACTITOL UND ANALOGA ZUR BEHANDLUNG VON NEOPLASTISCHEN ERKRANKUNGEN UND KREBSSTAMMZELLEN EINSCHLIESSLICH GLIOBLASTOMA MULTFORME UND MEDULLOBLASTOMA
SPC Number:

Dates

Filing date:
22/01/2013
Grant date:
04/12/2024
EP Publication Date:
26/11/2014
PCT Publication Date:
25/07/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
04/12/2024
EP B1 Publication Date:
04/12/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
22/01/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
27/11/2024
 
 

Name:
Del Mar Pharmaceuticals
Address:
Suite 115-887 Great Northern Way, Vancouver, Canada (CA)

Inventor

1

Name:
BROWN, Dennis
Address:
United States (US)

2

Name:
BACHA, Jeffrey
Address:
Canada (CA)

3

Name:
DUNN, Sandra
Address:
Canada (CA)

Priority

Priority Number:
201261589029 P
Priority Date:
20/01/2012
Priority Country:
United States (US)

Classification

IPC classification:
C07C 69/34; A61K 31/047; A61K 31/336; A61K 31/495; A61P 35/00;

Publication

European Patent Bulletin

Issue number:
202449
Publication date:
04/12/2024
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/07/2025
Annual Fee Number:
13
Annual Fee Amount:
180 Euro
Penalty Fee Amount:
20 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages